GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
GE HealthCare Technologies Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026
$69.76+0.19 (+0.27%)
Close on Oct 19, 2026
- Market cap
- $31.88B
- P/E (TTM)
- 16.7
- Dividend yield
- 0.20%
Share price
−$4.29 (−5.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
GE HealthCare Technologies Inc. grew revenue 6.0% to $20.98B over the twelve months to Mar 31, 2026. Operating income fell 2.4% to $2.65B, moving the operating margin from 13.7% to 12.6%. Free cash flow was $1.52B, up 10.2% from a year earlier.
Revenue
$20.98B
+6.0% vs. a year earlier
Operating income
$2.65B
-2.4% vs. a year earlier
Free cash flow
$1.52B
+10.2% vs. a year earlier
EPS, diluted
$4.18
-12.0% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2026
Valuation
- Market cap
- $31.88B
- P/E ratio
- 16.7
- Price to sales
- 1.52
- Price to book
- 2.99
- Dividend yield
- 0.20%
- Free cash flow yield
- 4.76%
Fundamentals
- Revenue
- $20.98B
- Net income
- $1.91B
- EPS, diluted
- $4.18
- Free cash flow
- $1.52B
- Book value per share
- $23.34
- Diluted shares
- 457M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
$20.98B+6.0% YoY
Gross profit
$8.21B-1.2% YoY
Operating income
$2.65B-2.4% YoY
Net income
$1.91B-12.5% YoY
EPS, diluted
$4.18-12.0% YoY
Free cash flow
$1.52B+10.2% YoY
Reported periodTrailing twelve months